Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3,035.00
  • Today's Change5.00 / 0.17%
  • Shares traded66.48k
  • 1 Year change67.31%
  • Beta1.3908
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2025202520242023
ASSETS
Cash And Short Term Investments484336
Total Receivables, Net119128136
Total Inventory818961
Prepaid expenses6.409.60--
Other current assets, total0.101.9025
Total current assets254271259
Property, plant & equipment, net379438442
Goodwill, net103110108
Intangibles, net556566
Long term investments666262
Note receivable - long term10128.20
Other long term assets01.204.90
Total assets899988966
LIABILITIES
Accounts payable2534--
Accrued expenses6970--
Notes payable/short-term debt000
Current portion long-term debt/capital leases161914
Other current liabilities, total212811
Total current liabilities131151147
Total long term debt250272218
Total debt266291232
Deferred income tax263441
Minority interest(0.1)(4.3)(7.7)
Other liabilities, total161824
Total liabilities423470422
SHAREHOLDERS EQUITY
Common stock6.606.606.60
Additional paid-in capital179179179
Retained earnings (accumulated deficit)322321330
Treasury stock - common(0.1)(0.1)(0.1)
Unrealized gain (loss)------
Other equity, total(31)1129
Total equity476518545
Total liabilities & shareholders' equity899988966
Total common shares outstanding666666
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.